BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10225562)

  • 1. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
    Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
    Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
    Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
    Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
    Tsang RW; Fyles AW; Li Y; Rajaraman MM; Chapman W; Pintilie M; Wong CS
    Radiother Oncol; 1999 Jan; 50(1):85-92. PubMed ID: 10225561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
    Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
    Gasinska A; Fowler JF; Lind BK; Urbanski K
    Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.
    Levine EL; Renehan A; Gossiel R; Davidson SE; Roberts SA; Chadwick C; Wilks DP; Potten CS; Hendry JH; Hunter RD
    Radiother Oncol; 1995 Oct; 37(1):1-9. PubMed ID: 8539450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
    Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
    Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
    Michel P; Paresy M; Lepessot F; Hellot MF; Paillot B; Scotte M; Peillon C; Ducrotté P; Hemet J
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):275-80. PubMed ID: 10750646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
    Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
    Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation kinetics and prognosis in gastric cancer after resection.
    Sendler A; Gilbertz KP; Becker I; Mueller J; Berger U; Fink U; van Beuningen D; Siewert JR
    Eur J Cancer; 2001 Sep; 37(13):1635-41. PubMed ID: 11527689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation parameters in epidermoid carcinomas of the anal canal.
    Wong CS; Tsang RW; Cummings BJ; Fyles AW; Couture J; Brierley JD; Pintilie M
    Radiother Oncol; 2000 Sep; 56(3):349-53. PubMed ID: 10974385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
    Gasinska A; Skolyszewski J; Glinski B; Niemiec J; Adamczyk A; Krzyszkowski T; Zabek M
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):459-65. PubMed ID: 16909969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT; Jones B; Gee A; Kingston RE
    Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.